Reversal of sorafenib resistance in hepatocellular carcinoma: epigenetically regulated disruption of 14-3-3η/hypoxia-inducible factor-1α
Yongxin Qiu(Jiangsu Cancer Hospital), Yuan Li(Fudan University Shanghai Cancer Center)
Cited by 54
Related Papers
ALK-Rearranged Lung Cancer in Chinese: A Comprehensive Assessment of Clinicopathology, IHC, FISH and RT-PCR
|PLoS ONE|2013|61
Blockage of TGFβ‐SMAD2 by demethylation‐activated miR‐148a is involved in caffeic acid‐induced inhibition of cancer stem cell‐like properties<i>in vitro</i> and<i>in vivo</i>
|FEBS Open Bio|2015|52
Copper in colorectal cancer: From copper‐related mechanisms to clinical cancer therapies
|Clinical and Translational Medicine|2024|47